Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells

Oncogene

Volumn 23, Issue 36, 2004, Pages 6163-6169

  Kawakami, Takahiro ^a   Zhang, Cheng ^a   Taniguchi, Takanobu ^b   Chul, Jang Kim ^a   Okada, Yusaku ^a   Sugihara, Hiroyuki ^a   Hattori, Takanori ^a   Reeve, Anthony E ^c   Ogawa, Osamu ^d   Okamoto, Keisei ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Female derived cancer; Klinefelter syndrome; X inactivation

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CELL; CHROMOSOME INACTIVATION; CHROMOSOME LOSS; CONTROLLED STUDY; DNA METHYLATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; KLINEFELTER SYNDROME; MALE; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; UTERINE CERVIX CANCER; X CHROMOSOME;

BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, X; DNA METHYLATION; DOSAGE COMPENSATION, GENETIC; FEMALE; GENES, P53; HUMANS; KLINEFELTER SYNDROME; MALE; NEOPLASMS; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; RNA, UNTRANSLATED; UTERINE CERVICAL NEOPLASMS;

EID: 4444381577     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207808     Document Type: Article

References (28)

1. Brown CJ, Carrel L and Willard HF. (1997). Am. J. Hum. Genet., 60, 1333-1343.
2. Dutrillaux B, Muleris M and Seureau MG. (1986). Int. J. Cancer, 38, 475-179.
3. Edelmann J, Hering S, Kuhlisch E and Szibor R. (2002). Forensic Sci. Int., 125, 217-222.
4. Edelmann J and Szibor R. (2001). Int. J. Legal Med., 114, 301-304.
5. Ganesan S, Silver DP, Greenberg RA, Avni D, Drapkin R, Miron A, Mok SC, Randrianarison V, Brodie S, Salstrom J, Rasmussen TP, Klimke A, Marrese C, Marahrens Y, Deng CX, Feunteun J and Livingston DM. (2002). Cell, 111, 393-405.
6. Giordano SH, Buzdar AU and Hortobagyi GN. (2002). Ann. Intern. Med., 137, 678-687.
7. Hasle H, Mellemgaard A, Nielsen J and Hansen J. (1995). Br. J. Cancer, 71, 416-420.
8. Hopman AH, Poddighe PJ, Smeets AW, Moesker O, Beck JL, Vooijs GP and Ramaekers FC. (1989). Am. J. Pathol., 135, 1105-1117.
9. Huang D, Yang Q, Yu C and Yang R. (2003). Forensic Sci. Int., 133, 246-249.
10. Huang KC, Rao PH, Lau CC, Heard E, Ng SK, Brown C, Mok SC, Berkowitz RS and Ng SW. (2002). Mol. Cancer Ther., 1, 769-776.
11. Jacobs PA and Strong JA. (1959). Nature, 183, 302-303.
12. Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR, Boyd J and Liu ET. (2002). J. Natl. Cancer Inst., 94, 990-1000.
13. Kawakami T, Okamoto K, Kataoka A, Koizumi S, Iwaki H, Sugihara H, Reeve AE, Ogawa O and Okada Y. (2003a). Genes Chromosomes Cancer, 38, 97-101.
14. Kawakami T, Okamoto K, Ogawa O and Okada Y. (2004). Lancet, 363, 40-42.
15. Kawakami T, Okamoto K, Sugihara H, Hattori T, Reeve AE, Ogawa O and Okada Y. (2003b). J. Urol., 169, 1546-1552.
16. Kim CJ, Kushima R, Okada Y and Seto A. (2000). Prostate, 42, 287-294.
17. Kirchgessner CU, Warren ST and Willard HF. (1995). J. Med. Genet., 32, 925-929.
18. Kokalj-Vokac N, Saint-Ruf C, Lefrancois D, Viegas-Pequignot E, Lemieux N, Malfoy B and Dutrillaux B. (1991). Cytogenet. Cell Genet., 57, 11-15.
19. Lyon MF. (1961). Nature, 190, 372-373.
20. McDonald HL, Gascoyne RD, Horsman D and Brown CJ. (2000). Genes Chromosomes Cancer, 28, 246-257.
21. Melki JR, Vincent PC and Clark SJ. (1999). Cancer Res., 59, 3730-3740.
22. Muleris M, Dutrillaux AM, Salmon RJ and Dutrillaux B. (1990). Genes Chromosomes Cancer, 1, 221-227.
23. Perry M. (1972). Br. J. Surg., 59, 731-734.
24. Savino A. (1971). Acta Cytol., 15, 372-374.
25. Smyth CM and Bremner WJ. (1998). Arch. Intern. Med., 158, 1309-1314.
26. Son JY, Lee YS, Choung CM and Lee SD. (2002). Int. J. Legal Med., 116, 317-321.
27. Stone C, McCabe N and Ashworth A. (2003). Curr. Biol., 13, R63-4.
28. Therman E, Denniston C, Nieminen U, Buchler DA and Timonen S. (1985). Cancer Genet. Cytogenet., 16, 1-11.